PTCT

PTC Therapeutics Inc.

Price

$73.67

return (12m)

48.56%

p/e

-154.09

p/bv

-35.77

DIVIDEND YIELD

0.00%

PTCT price

PTC Therapeutics

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment PTCT

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

-6.38%

3 months

5.56%

1 year

48.56%

2 years

113.78%

5 years

92.85%

10 years

0.00%

Asset Comparator

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Fundamentals PTCT

Valuation

P/E

-154.09

Sector -4.38

Industry -4.38

P/BV

-35.77

Sector 2.02

Industry 2.02

P/Revenue (PSR)

5.86

Sector -4.40

Industry -4.40

EV/EBITDA

26.07

Sector -263.09

Industry -263.09

EV/EBIT

28.90

Sector -702.90

Industry -702.90

P/EBITDA

34.08

Sector -4.39

Industry -4.39

P/EBIT

50.03

Sector -4.73

Industry -4.73

P/Total Assets

1.82

Sector 1.49

Industry 1.49

P/Net Current Assets

-7.41

Sector -11.70

Industry -11.70

P/Working Capital

3.20

Sector -3.19

Industry -3.19

EPS

-0.46

Sector -2.14

Industry -2.14

BVPS

-1.99

Sector 1.85

Industry 1.85

Efficiency

Gross Margin

92.99%

Sector 36.74%

Industry 36.74%

EBITDA Margin

44.91%

Sector -16,244.81%

Industry -16,244.81%

EBIT Margin

40.51%

Sector -4,202,541.34%

Industry -4,202,541.34%

Operating Margin

11.57%

Sector -38.22%

Industry -38.22%

Net Profit Margins

-3.80%

Sector -39.69%

Industry -39.69%

Asset Turnover

0.11

Sector 0.03

Industry 0.03

Profitability

ROE

23.21%

Sector -65.14%

Industry -65.14%

ROA

-1.18%

Sector -65.53%

Industry -65.53%

ROIC

39.75%

Sector -2,103.35%

Industry -2,103.35%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

3.39

Sector 2.90

Industry 2.90

Net Debt / EBITDA

-10.46

Sector -6.07

Industry -6.07

Net Debt / EBIT

-11.60

Sector -8.26

Industry -8.26

Net Debt / Equity

10.24

Sector -1.07

Industry -1.07

Gross Debt / Equity

-3.24

Sector -0.05

Industry -0.05

Equity/Assets

-0.05

Sector 0.41

Industry 0.41

Liabilities/Assets

1.05

Sector 0.39

Industry 0.39

Growth

5Y Revenue CAGR

13.37%

Sector -

Industry -

5Y Earnings CAGR

-40.71%

Sector -

Industry -

Fundamentals PTCT

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
PTCT PTC Therapeutics Inc.	$73.67	47.93%	0.00%	-154.09	-35.77	23.21%	-3.80%
JNJ Johnson & Johnson	$273.41	58.46%	2.02%	29.66	7.34	24.76%	21.48%
PFE Pfizer Inc.	$28.24	21.45%	6.54%	34.62	1.75	5.07%	6.80%
ABBV AbbVie Inc.	$265.97	33.11%	2.73%	70.02	-74.53	-106.44%	9.81%
NVO Novo Nordisk A/S	$46.48	-9.14%	4.09%	11.13	5.91	53.11%	35.32%
MRK Merck & Co. Inc.	$152.20	87.95%	2.45%	106.68	8.06	7.56%	4.77%
AZN AstraZeneca PLC	$164.95	4.92%	2.07%	22.98	4.77	20.74%	17.02%
BMY Bristol-Myers Squibb Company	$67.61	46.95%	3.93%	14.06	5.85	41.59%	18.87%
ZTS Zoetis Inc.	$76.68	-48.52%	2.77%	11.89	9.88	83.10%	27.49%
REGN Regeneron Pharmaceuticals Inc.	$840.84	43.05%	0.45%	19.09	2.61	13.65%	27.86%
AMGN Amgen Inc.	$442.36	55.11%	2.39%	25.30	18.93	74.80%	22.95%
HALO Halozyme Therapeutics Inc.	$107.62	56.06%	0.00%	27.82	80.17	288.14%	24.86%
MCK McKesson Corporation	$853.71	27.85%	0.38%	22.42	-79.15	-352.96%	1.12%
VRTX Vertex Pharmaceuticals Incorporated	$552.06	41.60%	0.00%	29.26	6.36	21.76%	35.00%
CAH Cardinal Health Inc.	$234.85	58.85%	0.88%	31.61	-19.89	-62.92%	0.67%
HRMY Harmony Biosciences Holdings Inc.	$39.93	9.67%	0.00%	12.18	2.21	18.14%	18.89%
BIIB Biogen Inc.	$221.56	63.02%	0.00%	37.04	1.64	4.43%	8.32%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

PTCT Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT PTC Therapeutics

PTC Therapeutics Inc.

Average Investor10 user rating

4.0 (1 people)

United States

28 years

Founded: 1998

2013

Time since IPO - 13 years

967

Employees

PTC Therapeutics Inc. (United States) is listed on the Nasdaq and has a market capitalization of $5.91 billion, with shareholders equity totaling $-165.36 million.

The company employs approximately 967 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, PTC Therapeutics Inc. reported $1.01 billion in revenue, generating net income of $-38.38 million.

Key financial metrics include a P/E ratio of -154.09, a price-to-book (P/B) ratio of -35.77, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker PTCT.

Market cap

$5.91 billion

Net worth

$-165.36 million

$-165,360,000.00

Assets

$3.25 billion

$3,250,480,000.00

Total Shares Outstanding

83.00 million

83,000,000

Average Daily Trading Volume

$1.87 million

$1,871,415.82

Sector

Health Care

Industry

Biotechnology

PTCT

PTCT revenue and profits

Financial Results PTCT

DRAG THE FRAME TO SEE MORE DATA

PTCT cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

$- -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$853.71 22,07% (12M)

P/E

22.42

0.38%

ROE

-352.96%

P/BV

-79.15

CAH - Cardinal Health

$234.85 55,51% (12M)

P/E

31.61

0.88%

ROE

-62.92%

P/BV

-19.89

JNJ - Johnson & Johnson

$273.41 57,54% (12M)

P/E

29.66

2.02%

ROE

24.76%

P/BV

7.34

ABBV - AbbVie

$265.97 31,23% (12M)

P/E

70.02

2.73%

ROE

-106.44%

P/BV

-74.53

MRK - Merck & Co.

$152.20 86,97% (12M)

P/E

106.68

2.45%

ROE

7.56%

P/BV

8.06

AZN - AstraZeneca

$164.95 5,00% (12M)

P/E

22.98

2.07%

ROE

20.74%

P/BV

4.77

PFE - Pfizer

$28.24 21,16% (12M)

P/E

34.62

6.54%

ROE

5.07%

P/BV

1.75

BFRA - Biofrontera

$- -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$853.71 22,07% (12 M)

P/L

22.42

0.38%

ROE

-352.96%

P/VP

-79.15

CAH - Cardinal Health

$234.85 55,51% (12 M)

P/L

31.61

0.88%

ROE

-62.92%

P/VP

-19.89

JNJ - Johnson & Johnson

$273.41 57,54% (12 M)

P/L

29.66

2.02%

ROE

24.76%

P/VP

7.34

ABBV - AbbVie

$265.97 31,23% (12 M)

P/L

70.02

2.73%

ROE

-106.44%

P/VP

-74.53

MRK - Merck & Co.

$152.20 86,97% (12 M)

P/L

106.68

2.45%

ROE

7.56%

P/VP

8.06

AZN - AstraZeneca

$164.95 5,00% (12 M)

P/L

22.98

2.07%

ROE

20.74%

P/VP

4.77

PFE - Pfizer

$28.24 21,16% (12 M)

P/L

34.62

6.54%

ROE

5.07%

P/VP

1.75

Frequently Asked Questions

What is the price of PTC Therapeutics (PTCT) today?

A cotação de PTC Therapeutics (PTCT) hoje está em US$ 73.67, com uma variação de 48.56% em relação ao último ano. A cotação de PTC Therapeutics (PTCT) iniciou o ano negociando na casa dos US$ 75.96 e hoje está em US$ 73.67. Acompanhe o gráfico de cotação em tempo real, a cotação histórica de PTC Therapeutics (PTCT) e dados de ações do Ibovespa e mercados internacionais.

Quando PTC Therapeutics (PTCT) paga dividendos?

PTC Therapeutics (PTCT) não distribuiu dividendos no último ano.

Is PTC Therapeutics (PTCT) a good investment?

Atualmente, PTC Therapeutics (PTCT) está cotada a US$ 73.67, com um P/L de -154.09, representando um desvio de -3,258% em relação ao seu P/L médio histórico. No último ano, a ação apresentou uma variação de 48.56 em sua cotação e distribuiu US$ 0.00 em dividendos, resultando em um Dividend Yield de 0.00%. O retorno total do acionista foi de 48.56%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy PTC Therapeutics (PTCT) stock?

Investir em ações de PTC Therapeutics (PTCT) pode ser feito de duas formas: comprando a stock uma empresa estrangeira e é atrelado ao dólar.

How much would 100 shares of PTC Therapeutics (PTCT) yield today?

A rentabilidade de PTC Therapeutics (PTCT) foi de -6.38% no último mês, 48.56% no último ano e 92.85% nos últimos 5 anos (já considerando valorização e dividendos).

Nos últimos 12 meses, a empresa pagou um total de US$ 0.00 em dividendos, um Dividend Yield de 0.00%.

Se você quisesse comprar 100 ações de PTC Therapeutics (PTCT) hoje, o investimento total seria de US$ 7,367.00, com base na cotação atual de US$ 73.67.

Based on historical performance, the investment would have grown to approximately:

Em 1 ano: US$ 10,944.42
Em 5 anos: US$ 14,207.26
Em 10 anos: US$ 7,367.00

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

PTCT

PTC Therapeutics Inc.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment PTCT

Valuation

Efficiency

Profitability

Dividends

Debt

Growth

COMPARING PTCT WITH OTHER STOCK

current DY: 0.00%

5-year average DY: 0.00%

ABOUT PTC Therapeutics

PTC Therapeutics Inc.

United States

28 years

2013

967

PROFIT X PRICE PTCT

Financial Results PTCT

PTCT cash flow

Asset, Revenue and Profit Growth - PTCT

PTCT balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

Frequently Asked Questions